Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields

Details for Australian Patent Application No. 2007255038 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Brighton, Carl T.

Agent Watermark

Pub. Number AU-B-2007255038

PCT Pub. Number WO2007/142901

Priority 11/444,179 31.05.06 US

Filing date 29 May 2007

Wipo publication date 13 December 2007

Acceptance publication date 17 March 2011

International Classifications

A61N 1/00 (2006.01) Electrotherapy

A61N 1/32 (2006.01) Electrotherapy - alternating or intermittent currents

A61N 1/40 (2006.01) Electrotherapy - Applying electric fields by inductive or capacitive coupling

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C12N 13/00 (2006.01) Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/142901 Priority application(s): WO2007/142901

17 March 2011 Application Accepted

  Published as AU-B-2007255038

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255041-Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands

2007255025-Aminothiazole derivatives and their uses as antibacterial agents